Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Generic Drug User Fee Projections Complicated By Shifting Personnel Costs
Dec 04 2020
•
By
Derrick Gingery
The FDA and industry are discussing potential changes to GDUFA user fee calculations as part of renewal negotiations. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from Pathways & Standards